Quantbot Technologies LP Bridge Bio Pharma, Inc. Transaction History

Quantbot Technologies LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $33,868 - $61,884	1,410 New	1,410 $56,000
Q1 2023 May 12, 2023	BUY	$7.17 - $18.55 $20,076 - $51,940	2,800 New	2,800 $46,000
Q3 2022 Nov 07, 2022	BUY	$7.94 - $12.36 $246,362 - $383,506	31,028 Added 1577.43%	32,995 $327,000
Q2 2022 Aug 09, 2022	SELL	$5.21 - $12.14 $11,633 - $27,108	-2,233 Reduced 53.17%	1,967 $17,000
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $25,690 - $60,060	3,500 Added 500.0%	4,200 $42,000
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $123,564 - $579,925	-10,858 Reduced 93.94%	700 $11,000
Q3 2021 Nov 09, 2021	BUY	$46.87 - $64.24 $433,922 - $594,733	9,258 Added 402.52%	11,558 $541,000
Q2 2021 Aug 12, 2021	BUY	$46.47 - $63.93 $106,881 - $147,039	2,300 New	2,300 $140,000
Q1 2021 May 14, 2021	SELL	$55.47 - $72.35 $61,017 - $79,585	-1,100 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $26,866 - $49,777	700 Added 175.0%	1,100 $78,000
Q3 2020 Nov 16, 2020	BUY	$27.2 - $42.19 $10,880 - $16,876	400 New	400 $15,000

294

170M

10.4M

2.36M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.57B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.